Hyro, a company developing specialized AI agents for the American healthcare system, has raised $45 million in a funding round led by Healthier Capital, with participation from Norwest and Define Ventures, as well as other existing investors. The round also included new strategic investments from Bon Secours Mercy Health, one of Hyro’s long-standing clients, and ServiceNow Ventures, the investment arm of ServiceNow. The financing comes just 10 months after Hyro’s previous raise and doubles the company’s valuation to several hundred million dollars, bringing total funding to $95 million.
Hyro’s last funding round was $15 million, which itself was an extension of a $20 million Series B completed in 2023. Previous investors included Liberty Mutual Strategic Ventures, Black Opal Ventures, K20, Hanaco Ventures, Spero Ventures, and Mindset Ventures, though none of these participated in the current round. Healthier Capital is the only returning investor.
Founded in 2018 by Israel Krush and Rom Cohen, Hyro is registered in the U.S. and headquartered in New York, with most of its 130 employees based in Tel Aviv (80) and the remainder in the U.S. (50).
Interest in Hyro has surged amid the broader AI revolution, even though the company was founded seven years ago, well before the major breakthroughs in artificial intelligence. Initially, the founders sought to apply natural language technologies for automated voice communication with enterprise service centers. By 2020, Hyro began marketing its solutions, but the AI boom prompted a shift toward the healthcare sector.
Today, Hyro’s platform enables patients to complete tasks such as booking doctor appointments or renewing prescriptions through voice service centers, reducing personnel costs for healthcare providers. Its clients include major U.S. healthcare organizations such as Intermountain Health, Baptist Health, and Hackensack Meridian Health, with deployments in hospitals and medical centers including Sutter Health, Tampa General Hospital, Prisma Health, and Piedmont Healthcare.
The U.S. healthcare system faces complex challenges, including multiple providers, bureaucratic processes, and limited, overstretched service centers. Staff shortages, burnout, and employee attrition further strain the system. AI-based automation platforms like Hyro’s can shorten wait times, reduce call-center workloads, improve patient experiences, and enhance access to care. Hyro reports that its system, which integrates voice, chat, and text capabilities, resolves 85% of calls without human intervention.
“After another 10 months of strong execution, landing new enterprise customers and expanding relationships with existing ones, we decided to bring on additional capital to further our mission of improving patient access to care and driving operational excellence for health systems,” said Krush. “There are plenty of impressive demos in the market, but what healthcare organizations need are AI agents that are patient-ready and enterprise-ready today, designed around proven real-world workflows and best practices, deeply interoperable with EMR systems like Epic, and reinforced with robust safeguards. This new funding round reflects the industry’s growing trust in our approach. With support from both new strategic investors and long-time partners, we’re well-positioned to expand across new specialties and segments throughout the healthcare ecosystem.”
“Healthcare is highly complex. What excites us about Hyro is their combination of advanced AI agents with deep healthcare-native design and safety mechanisms,” said Assaf Harel, Partner at Norwest. “Healthcare organizations need more than just polished chatbots, they need platforms that integrate seamlessly with EHRs, CRMs and clinical workflows embedded deep within the complex U.S. care ecosystem. Hyro is already proving it can deliver this at scale, and we believe it’s positioned to become the definitive AI communications layer for healthcare.”